Results 181 to 190 of about 295,397 (306)

A novel surface plasmon resonance approach to assess anti‐dsDNA antibody kinetics and disease severity in systemic lupus erythematosus

open access: yesClinical &Translational Immunology, Volume 15, Issue 1, 2026.
An innovative FO‐SPR biosensor for anti‐dsDNA kinetic profiles to differentiate SLE patients with or without nephritis. Maximal FO‐SPR binding correlates with disease activity in lupus nephritis. Abstract Objectives Anti‐dsDNA antibodies are established biomarkers in systemic lupus erythematosus (SLE), yet the clinical utility of conventional assays ...
Carole Nagant   +6 more
wiley   +1 more source

#317 Autophagy related Protein 5 is a promising autophagy marker in lupus nephritis with good predictive value of response to treatment [PDF]

open access: bronze
Howayda El Shinnawy   +5 more
openalex   +1 more source

Bullous Systemic Lupus Erythematosus With Lupus Nephritis [PDF]

open access: bronze, 2023
Meryl Musicante   +2 more
openalex   +1 more source

Type 1 Diabetes and Other Autoimmune Diseases—Epidemiology, Pathophysiology and Screening

open access: yesEndocrinology, Diabetes &Metabolism, Volume 9, Issue 1, January 2026.
Individuals with type 1 diabetes exhibit significantly increased prevalence of additional autoimmune diseases. Epidemiological, familial and mechanistic evidence indicates frequent polyautoimmunity and shared genetic and environmental drivers. Coexistence complicates clinical management, and autoantibody‐based detection often identifies preclinical ...
George J. Kahaly   +6 more
wiley   +1 more source

Therapeutic Potential of Irpex lacteus Polysaccharides in Lupus Nephritis: Insights From Gut Microbiota and Metabolomics Analysis in MRL/Lpr Mice

open access: yesFood Science &Nutrition, Volume 14, Issue 1, January 2026.
Polysaccharides from Irpex lacteus alleviated kidney inflammatory response. PCP could reverse the phenotype of MRL/lpr mice, reduce autoantibody levels, alleviate inflammatory responses, and improve renal function. Improving the body's metabolism by gut microbes may be the possible mechanism of PCP in treating LN.
Guoxin Ji   +9 more
wiley   +1 more source

Prognostic Factors for Complications Following Ultrasound‐Guided Percutaneous Kidney Biopsy: A 7‐Year Retrospective Study

open access: yesJournal of Clinical Ultrasound, Volume 54, Issue 1, Page 23-32, January 2026.
Complications were common but mostly minor following ultrasound‐guided percutaneous kidney biopsy. Older age, obesity, and smoking were independently associated with a reduced risk of complications, including hematoma. These findings highlight the overall safety of the procedure and support individualized risk assessment based on patient ...
Sehyun Jung   +5 more
wiley   +1 more source

Regulation and Mechanism of Deleted in Breast Cancer‐1 on Dendritic Cell Function in Systemic Lupus Erythematosus

open access: yesMedComm, Volume 7, Issue 1, January 2026.
LPS‐stimulated DC activation upregulated DBC1. DBC1‐deficient DC ameliorated murine SLE symptoms. DBC1 deficiency suppressed immune responses in DC. DBC1 deficiency lowered STAT5 expression and subsequent phosphorylation. STAT5 overexpression abolished murine SLE remission primed by DBC1 deficiency.
Ze Xiu Xiao   +9 more
wiley   +1 more source

KDIGO 2024 Clinical Practice Guideline for the management of LUPUS NEPHRITIS.

open access: yesKidney International
Brad H. Rovin   +5 more
semanticscholar   +1 more source

Fibroblast‐specific palladin drives kidney fibrosis via MRTF–SRF signaling

open access: yesThe Journal of Pathology, Volume 268, Issue 1, Page 40-53, January 2026.
Abstract Fibrosis is a common end‐stage pathway of progressive chronic kidney diseases. Previously we demonstrated that myocardin‐related transcription factor (MRTF)–serum response factor (SRF) signaling drives the expression of fibrosis‐related molecules through actin cytoskeleton dynamics in renal fibroblasts.
Naoki Yamamoto   +27 more
wiley   +1 more source

Home - About - Disclaimer - Privacy